AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

RAD51C

Summary

RAD51C as a novel susceptibility gene for hereditary breast and ovarian cancer.

Technology Benefits

RAD51C as a novel susceptibility gene for hereditary: breast cancer, ovarian cancer, head and neck squamous cell carcinomas (HNSCC).
RAD51C as companion diagnostic for PARP or TOPO I Inhibitors.

Technology Application

Professional societies and health care systems, risk-adapted personalized treatment, identify individuals with germline and/or somatic mutation(s) in cancer risk genes

Detailed Technology Description

A novel susceptibility gene for hereditary cancers. RAD51C, which encodes for a protein involved in DNA repair, has been found to be mutated in families with breast and ovarian cancer, but not in healthy control subjects

Type of Cooperation

Licensing

Application Date

09/04/2010 00:00:00

Application No.

EP20100159524 20100409

Classes

- international:
C12Q1/68
- cooperative:
C12Q1/6886; C12Q2600/106; C12Q2600/156

Others

Patent application

ID No.

2301

Country/Region

Germany

For more information, please click Here